Rchr
J-GLOBAL ID:201801018467436508   Update date: Jun. 02, 2024

Fujita Shiro

フジタ シロウ | Fujita Shiro
Affiliation and department:
Other affiliations (1):
  • Nagasaki University  Department of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences 
Research field  (3): Tumor biology ,  Genetics ,  Respiratory medicine
Research keywords  (4): Hereditary cancer ,  Next generation sequencing ,  Lung cancer ,  Interstitial lung disease
Research theme for competitive and other funds  (4):
  • 2020 - 2023 KRAS mutations in lung cancer
  • 2016 - 2020 Analysis of PD-L1 up-regulation mechanism induced by radiotherapy using a next-generation sequencer
  • 2015 - 2019 Genomic alterations of non-small-cell lung cancer following radiotherapy
  • 2022 HiFi for Accuracy SMRT Grant winners
Papers (189):
  • Ethan N. Okoshi, Shiro Fujita, Kris Lami, Yuka Kitamura, Ryuta Matsuda, Takuro Miyazaki, Keitaro Matsumoto, Takeshi Nagayasu, Junya Fukuoka. Differential Gene Expression of Tumors Undergoing Lepidic-Acinar Transition in Lung Adenocarcinoma. 2024
  • Eiichi Sasaki, Katsuhiro Masago, Yoshihito Kogure, Shiro Fujita, Akari Iwakoshi, Hiroaki Kuroda, Toyonori Tsuzuki, Koji Tsuta, Hirokazu Matsushita, Masahide Oki. Mucous Gland Adenoma of the Lung: A Neoplastic Counterpart of Mucinous Bronchial Glands. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2023. 36. 6. 100182-100182
  • Katsuhiro Masago, Hiroaki Kuroda, Eiichi Sasaki, Shiro Fujita, Shuichi Shinohara, Yusuke Sugita, Yusuke Takahashi, Hirokazu Matsushita. Association of the KRAS genotype and clinicopathologic findings of resected non-small-cell lung cancer: A pooled analysis of 179 patients. Cancer genetics. 2022. 268-269. 64-74
  • Katsuhiro Masago, Hiroaki Kuroda, Shiro Fujita, Eiichi Sasaki, Yusuke Takahashi, Shuichi Shinohara, Hirokazu Matsushita. Biological difference between L858R and exon 19 deletion contributes to recurrence-free survival of resected non-small cell lung cancer. Oncology. 2022. 101. 2. 117-125
  • Katsutoshi Seto, Junichi Shimizu, Katsuhiro Masago, Mitsugu Araki, Ryohei Katayama, Yukari Sagae, Shiro Fujita, Yoshitsugu Horio, Eiichi Sasaki, Hiroaki Kuroda, et al. Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancer. Cancer genetics. 2022. 266-267. 1-6
more...
MISC (116):
Books (1):
  • いそがしい医療従事者のための遺伝子バリアント評価法
    中外医学社 2022 ISBN:4498008545
Lectures and oral presentations  (1):
  • Ion Torrentの原理と操作法
    (がんの個別化医療の実用化に向けた解析・診断システムの構築研究 2018)
Association Membership(s) (5):
American Society of Human Genetics ,  The Japanese Society for Hereditary Tumors ,  日本人類遺伝学会 ,  The Japanese Respiratory Society ,  The Japanese Society of Internal Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page